The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy
NCT01633528 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2017-01-18
Summary
It has been reported that low-dose aspirin and Heparin would lead to an increased Pregnancy rate in patients undergoing IVF-ET. Low-dose aspirin may improve uterine and ovarian perfusion and that aspirin might enhance endometrial receptivity and ovarian responsiveness as well, which could result in better implantation and pregnancy rates after IVF or ICSI treatment. This study assesses potential effects of low-dose aspirin (100 mg daily) on pregnancy rate following frozen embryo transfer.
Conditions
Interventions
- DRUG
-
Asprin
100 mg
- DRUG
-
100mg
Sponsors & Collaborators
-
Royan Institute
lead OTHER_GOV
Principal Investigators
-
Hamid Gourabi, PhD · Head of Royan institute
-
Tahereh Madani, MD · Endocrinology and Female Infertility Department
-
Firoozeh Ahmadi, MD · Reproductive Imaging Department
-
Poopak Eftekhary, PhD · Embryology Department
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2012-09-30
- Completion
- 2015-02-28
Countries
- Iran
Study Locations
More Related Trials
-
Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)
NCT02409680 ·Status: COMPLETED ·Phase: NA
-
Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting
NCT00966485 ·Status: COMPLETED ·Phase: NA
-
Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT
NCT00564174 ·Status: TERMINATED ·Phase: NA
-
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
NCT01276691 ·Status: COMPLETED ·Phase: PHASE4
-
Asprin Dosing Estimator in Healthy Adults
NCT04040465 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation
NCT01616615 ·Status: COMPLETED ·Phase: PHASE2
-
Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion
NCT00959621 ·Status: COMPLETED ·Phase: PHASE3
-
IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes
NCT03574909 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin in Reducing Events in the Elderly
NCT01038583 ·Status: UNKNOWN
-
Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People
NCT00793754 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases
NCT01867281 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
NCT00501345 ·Status: TERMINATED ·Phase: PHASE3
-
Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?
NCT00578760 ·Status: UNKNOWN ·Phase: NA
-
Testing a Community Intervention to Increase Aspirin Use
NCT02607917 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease
NCT01320072 ·Status: TERMINATED
-
Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients
NCT00812032 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate
NCT00861367 ·Status: WITHDRAWN ·Phase: NA
-
Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients
NCT04269863 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety Study of Aspirin for the Prevention of Renal Artery Stenosis in Renal Transplantation Recipients
NCT04260828 ·Status: UNKNOWN ·Phase: PHASE4
-
First Approach for Aspirin Misuse Objective Screening
NCT02997436 ·Status: COMPLETED ·Phase: NA
-
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers
NCT02123849 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet
NCT04792723 ·Status: UNKNOWN ·Phase: PHASE1
-
Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery
NCT01466452 ·Status: UNKNOWN ·Phase: PHASE2
-
Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
NCT05797597 ·Status: UNKNOWN ·Phase: PHASE3
-
Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular Disease
NCT03757156 ·Status: UNKNOWN ·Phase: NA